Canopy Growth Corporation (CGC) Cash Flow Statement

The volatility in the OCF-to-net income ratio — as extreme as 10.97x in 2026Q2 against 0.12x in 2026Q4 — suggests the reported loss line is dominated by episodic non-cash items, most plausibly impairments, rather than by recurring cash losses. The most recent quarter is the clearest illustration: a $25.0M operating cash outflow against a modest $14.6M net loss implies roughly $10M of D&A plus additional non-cash reversals are propping up the headline figure. For investors, this means the earnings-quality gap is directionally positive, but it also signals that the asset base is being written down faster than it is being monetized, which warrants further investigation into the composition of those charges.

The trajectory from roughly $56M of quarterly burn to the $18M–$26M range is real and consistent with the narrowing losses seen in the income statement, but the improvement is not monotonic — 2027Q1 was materially worse than 2026Q1 (-$11.8M), which cautions against reading a clean trend line. Critically, much of the improvement coincides with working capital releases rather than margin expansion, so it may reflect balance sheet timing rather than a genuine operating turn. Given that the latest quarter also saw a $6.6M working capital draw alongside revenue softness off the 2026Q3 peak, investors should monitor whether FCF burn stabilizes in the $20M range or re-widens.

For a company positioned as a cultivator and manufacturer of physical product, a CapEx-to-revenue ratio that has compressed from 5.9% to 0.9% is unusual and appears to imply either deliberate asset harvesting or an inability to justify new capacity at current utilisation. The gap between $0.25M–$3.9M of quarterly capex and roughly $10M of D&A means the balance sheet is being drained of plant and equipment value without offsetting replacement. This may be defensible while demand softens, but if revenue recovers toward the $100M quarterly level seen in 2026Q3, the underinvestment could become a constraint on throughput or product quality that management would need to address.

The absence of a stable directional trend in working capital — alternating between large releases and equally large draws — makes it difficult to separate genuine operational efficiency from timing effects, and suggests that receivables and inventory management have not yet settled into a predictable cycle. The 2026Q4 inflow of $15.2M is notable because it arrived alongside a sharp revenue decline and heavy net loss, which may indicate inventory liquidation or collection acceleration rather than healthy demand-driven conversion. The subsequent $6.6M outflow in 2027Q1, coinciding with a revenue recovery, could imply working capital is being rebuilt to support sales, though the sample is too short to confirm that interpretation.

A divergence of this magnitude, with D&A alone contributing approximately $100.9M, points toward large-scale non-cash write-downs of cultivation, processing, and brand assets — an interpretation consistent with the episodic loss spikes such as the $220.8M in 2025Q4 against only $33.2M of operating cash outflow. From an analytical standpoint, this means the company's cash position is meaningfully more resilient than the cumulative earnings record suggests, which is an important counterweight to the income statement's picture of structural insolvency. However, cumulative FCF of approximately -$294.5M still represents real cash that must come from financing or asset sales, so the divergence softens the optics without removing the funding dependency, and investors should monitor whether the cash burn continues to decouple from reported losses.